[PDF][PDF] Resveratrol supplementation in patients with non-alcoholic fatty liver disease: systematic review and meta-analysis.
A Elgebaly, IAI Radwan, MM AboElnas… - … of gastrointestinal & …, 2017 - academia.edu
Background: Resveratrol is a potential treatment option for management of non-alcoholic
fatty liver disease (NAFLD) due to its anti-inflammatory, antioxidant properties, and calorie …
fatty liver disease (NAFLD) due to its anti-inflammatory, antioxidant properties, and calorie …
Resveratrol Supplementation in Patients with Non-Alcoholic Fatty Liver Disease: Systematic Review and Meta-analysis.
A Elgebaly, IA Radwan, MM AboElnas… - … and Liver Diseases …, 2017 - europepmc.org
Background Resveratrol is a potential treatment option for management of non-alcoholic
fatty liver disease (NAFLD) due to its anti-inflammatory, antioxidant properties, and calorie …
fatty liver disease (NAFLD) due to its anti-inflammatory, antioxidant properties, and calorie …
Resveratrol Supplementation in Patients with Non-Alcoholic Fatty Liver Disease: Systematic Review and Meta-analysis
A Elgebaly, IAI Radwan… - … and liver diseases …, 2017 - pubmed.ncbi.nlm.nih.gov
Background Resveratrol is a potential treatment option for management of non-alcoholic
fatty liver disease (NAFLD) due to its anti-inflammatory, antioxidant properties, and calorie …
fatty liver disease (NAFLD) due to its anti-inflammatory, antioxidant properties, and calorie …
Resveratrol supplementation in patients with non-alcoholic fatty liver disease: systematic review and meta-analysis.
A Elgebaly, IAI Radwan, MM AboElnas, HH Ibrahim… - 2017 - cabidigitallibrary.org
Background: Resveratrol is a potential treatment option for management of non-alcoholic
fatty liver disease (NAFLD) due to its anti-inflammatory, antioxidant properties, and calorie …
fatty liver disease (NAFLD) due to its anti-inflammatory, antioxidant properties, and calorie …
[PDF][PDF] Resveratrol Supplementation in Patients with Non-Alcoholic Fatty Liver Disease: Systematic Review and Meta-analysis
A Elgebaly, IAI Radwan, MM AboElnas… - J Gastrointestin …, 2017 - researchgate.net
Background: Resveratrol is a potential treatment option for management of non-alcoholic
fatty liver disease (NAFLD) due to its anti-inflammatory, antioxidant properties, and calorie …
fatty liver disease (NAFLD) due to its anti-inflammatory, antioxidant properties, and calorie …
Resveratrol Supplementation in Patients with Non-Alcoholic Fatty Liver Disease: Systematic Review and Meta-analysis.
A Elgebaly, IAI Radwan, MM AboElnas… - … of Gastrointestinal & …, 2017 - search.ebscohost.com
Background: Resveratrol is a potential treatment option for management of non-alcoholic
fatty liver disease (NAFLD) due to its anti-inflammatory, antioxidant properties, and calorie …
fatty liver disease (NAFLD) due to its anti-inflammatory, antioxidant properties, and calorie …
Resveratrol Supplementation in Patients with Non-Alcoholic Fatty Liver Disease: Systematic Review and Meta-analysis.
A Elgebaly, IAI Radwan, MM AboElnas… - … of Gastrointestinal & …, 2017 - search.ebscohost.com
Background: Resveratrol is a potential treatment option for management of non-alcoholic
fatty liver disease (NAFLD) due to its anti-inflammatory, antioxidant properties, and calorie …
fatty liver disease (NAFLD) due to its anti-inflammatory, antioxidant properties, and calorie …